T 2101/09 (Human Delta3 - Notch/MILLENNIUM) of 26.02.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T210109.20130226
- Date of decision
- 26 February 2013
- Case number
- T 2101/09
- Petition for review of
- -
- Application number
- 98915305.1
- IPC class
- C12N 15/12
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Novel human delta3 compositions and therapeutic and diagnostic uses therefor
- Applicant name
- MILLENNIUM PHARMACEUTICALS, INC.
- Opponent name
- REGENERON PHARMACEUTICALS, INC.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 57European Patent Convention Art 83European Patent Convention Art 84European Patent Convention R 80Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Admissibility of Main Request (yes) and of new documents (no)
Main Request - amendments occasioned by opposition grounds (yes); extension of protection (no), clarity (yes), sufficiency of discloure and industrial applicability (yes), novelty and inventive step (yes) - Catchword
- -
- Citing cases
- T 1708/18
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of claims 1 to 9 of the new Main Request filed during the oral proceedings and the description to be adapted thereto.